The use of HMME-PDT is associated with a positive response and is well-tolerated among patients with facial port-wine stains.

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

SSDI to the standard of care for melanoma screening among patients at high-risk increased the number of excisions performed.

ACIP recommends pentavalent meningococcal vaccine Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) for individuals 10 through 25 years of age.

Pertussis cases are increased this year vs 2024, potentially due in part to lower vaccination rates among children.

The general fertility rate among women in the US increased slightly from 2023 to 2024, but it decreased among teens.

Patients with palmoplantar pustulosis have a high disease burden, with younger patients and those with nail involvement having worse quality of life.

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics may also be considered.

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

Adults with acne were found to be significantly more likely to have an eating disorder, even accounting for comorbid mental health disorders.

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.